Overview

RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant

Status:
Enrolling by invitation
Trial end date:
2025-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether TNFa antibody use before lung transplant can prevent kidney injury after lung transplant.
Phase:
Early Phase 1
Details
Lead Sponsor:
Northwestern University
Treatments:
Etanercept